MYO5B Deficiency-Associated Cholestasis and the Role of the Bile Salt Export Pump

Variants of the <i>MYO5B</i> gene, which encodes the molecular motor protein myosin-Vb, have gained prominence as a causative factor in familial intrahepatic cholestasis (FIC). Understanding the disease mechanism is pivotal for therapy development and clinical decision-making. The prevailing theory for the mechanism underlying <i>MYO5B</i>-associated cholestasis implicates faulty trafficking of the <i>ABCB11</i>-encoded bile salt export pump (BSEP) in hepatocytes due to dysfunctional myosin-Vb. This is supported by cell and mouse studies. However, while BSEP localization was abnormal in some patients' liver biopsies, BSEP appeared normally localized in others, raising questions with regard to the role of BSEP in <i>MYO5B</i>-associated FIC. We present a focused systematic narrative review of all cases of <i>MYO5B</i> variant-associated isolated FIC reported in the MEDLINE database. We assembled a comprehensive patient dataset and assessed clinical features of <i>MYO5B</i>-associated FIC, their relationship with <i>MYO5B</i> genotype, the clinical value and significance of BSEP abnormalities, and the relationship of <i>MYO5B</i>-associated FIC to <i>ABCB11</i> variant-associated FIC. Our review revealed that aberrant BSEP localization correlated with the absence of one <i>MYO5B</i> allele carrying a truncating nonsense or frameshift variant. Notably, biochemical and clinical parameters including treatment outcome were indistinguishable between patients presenting with normal and aberrant BSEP localization. Further, myosin-Vb and BSEP deficiency-associated FIC patient cohorts showed distinct biochemical and clinical phenotypes, indicating different underlying mechanisms. This suggests that whether or not BSEP localization was abnormal depended on the <i>MYO5B</i> genotype without a predictable effect on clinical parameters and treatment response. Treatment decisions should be guided by clinical parameters rather than by genotype or immunohistochemistry findings.

Authors

Institutions

Publication Details

Journal
Cells
Published
2026-01-05
DOI
https://doi.org/10.3390/cells15010092
Primary Topic
Drug Transport and Resistance Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MYO5B Deficiency-Associated Cholestasis and the Role of the Bile Salt Export Pump

Sven C. D. van IJzendoorn, Zhe Zhou
Cells
Drug Transport and Resistance Mechanisms
article

MYO5B Deficiency-Associated Cholestasis and the Role of the Bile Salt Export Pump

Sven C. D. van IJzendoorn, Zhe Zhou
article en

Abstract

Variants of the <i>MYO5B</i> gene, which encodes the molecular motor protein myosin-Vb, have gained prominence as a causative factor in familial intrahepatic cholestasis (FIC). Understanding the disease mechanism is pivotal for therapy development and clinical decision-making. The prevailing theory for the mechanism underlying <i>MYO5B</i>-associated cholestasis implicates faulty trafficking of the <i>ABCB11</i>-encoded bile salt export pump (BSEP) in hepatocytes due to dysfunctional myosin-Vb. This is supported by cell and mouse studies. However, while BSEP localization was abnormal in some patients' liver biopsies, BSEP appeared normally localized in others, raising questions with regard to the role of BSEP in <i>MYO5B</i>-associated FIC. We present a focused systematic narrative review of all cases of <i>MYO5B</i> variant-associated isolated FIC reported in the MEDLINE database. We assembled a comprehensive patient dataset and assessed clinical features of <i>MYO5B</i>-associated FIC, their relationship with <i>MYO5B</i> genotype, the clinical value and significance of BSEP abnormalities, and the relationship of <i>MYO5B</i>-associated FIC to <i>ABCB11</i> variant-associated FIC. Our review revealed that aberrant BSEP localization correlated with the absence of one <i>MYO5B</i> allele carrying a truncating nonsense or frameshift variant. Notably, biochemical and clinical parameters including treatment outcome were indistinguishable between patients presenting with normal and aberrant BSEP localization. Further, myosin-Vb and BSEP deficiency-associated FIC patient cohorts showed distinct biochemical and clinical phenotypes, indicating different underlying mechanisms. This suggests that whether or not BSEP localization was abnormal depended on the <i>MYO5B</i> genotype without a predictable effect on clinical parameters and treatment response. Treatment decisions should be guided by clinical parameters rather than by genotype or immunohistochemistry findings.

CellsVol. 15(1)
University Medical Center Groningen (NL), University of Groningen (NL)
China Scholarship Council
Peace, Justice and strong institutions
Openalex Percentile: Top 97%
Drug Transport and Resistance Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.